KNC Laboratories Co., Ltd.
Notice Regarding Changes in Major Shareholders
On August 10, 2026, following treasury stock acquisition, major shareholder Hitoshi Miyauchi sold a portion of his holdings, resulting in a change in major shareholders. Voting rights ratios before and after the change were 10.51% and 9.87%, reflecting adjustments to the total number of voting rights. No impact on future performance or management is noted.
Key Figures
- Before change: 813,000 shares
- After change: 753,000 shares
- Voting rights share (before): 10.51%
- Voting rights share (after): 9.87%
AI要約
Key points of the news
As of August 10, there has been a change in major shareholders due to treasury stock acquisition. Mr. Hitoshi Miyauchi sold 60,000 shares out of his 813,000 shares. Post-change voting rights holdings are 7,530 units (9.87%), making him the second-largest shareholder. The calculation of total shareholder voting rights takes into account treasury stock-related shares for restricted stock with conversion and paid-in capital; no impact on future performance or management is noted.
Impact on shareholders and outlook
Any dilution or changes in influence are considered limited, and there are no material notes regarding future earnings outlook or management alterations. The change in major shareholders affects shareholder composition but remains at the level of publicly disclosed information, with no short-term strategic changes indicated.
Kobe Translational Organic Chemistry Co., Ltd.
Company overview · Stock price · Financial data · All IR
